1. P01.18 Metabolic status and immune activation influence clinical outcomes in patients after allogeneic hematopoietic stem cell transplantation. (1st October 2020) Authors: Althoff, K; Leitzke, S; Herling, C; Frenzel, L; Herling, M; Holtick, U; Scheid, C; von Bergwelt-Baildon, M; Theurich, S Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 2 Page Start: A17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P03.16 Functional defects in B-cells of patients with von-Hippel-Lindau Syndrome. (1st October 2020) Authors: Theurich, S; Becker, HJ; Wennhold, K; Schlösser, H; Marbach, F; Garcia-Marquez, M; Shimabukuro-Vornhagen, A; Schreml, J; von Bergwelt-Baildon, M Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 2 Page Start: A29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P06.05 IDO1-deleted CAR T cells show improved therapeutic efficacy in murine pancreatic cancer models. (1st October 2020) Authors: Senz, AM; Metzger, P; Rubens, RK; Cadilha, B; Kirmaier, M; Lesch, S; Benmebarek, MR; Theurich, S; Murray, P; Endres, S; Kobold, S; König, LM; Duewell, P; Schnurr, M Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 2 Page Start: A43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P60. Microtubule-depolymerising agents used in antibody-drug-conjugates induce anti-tumour immunity by stimulation of dendritic cells. (12th March 2014) Authors: Martin, K; Mueller, P; Theurich, S; Savic, S; Terszowski, G; Kvasnicka, HM; Dirnhofer, S; Speiser, DE; von Bergwelt-Baildon, M; Zippelius, A Journal: Journal for immunotherapy of cancer Issue: Volume 2(2014)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗